Pandion Therapeutics, Inc.
Pandion Therapeutics, Inc. (PAND) is a publicly traded company in the Unknown sector. Across all available filings, 21 corporate insiders have executed 77 transactions totaling $65.5M, demonstrating a bullish sentiment with $65.5M in net insider flow. The most recent transaction on Apr 1, 2021 involved a transaction of 22,125 shares valued at $1.3M.
PAND Insider Activity Summary
Who Is Buying PAND Stock?
No significant insider buying has been recorded for PAND in the recent period.
Who Is Selling PAND Stock?
No significant insider selling has been recorded for PAND in the recent period.
Is Pandion Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for PAND is bullish with an Insider Alignment Score of 100/100 and a net flow of $65.5M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
PAND Frequently Asked Questions
Understanding PAND Insider Activity
Insider trading at Pandion Therapeutics, Inc. (PAND) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 21 insiders are actively trading PAND stock, having executed 77 transactions in the past 90 days. The most active insider is Jill Carroll (Executive), who has made 4 transactions totaling $347.0M.
Related Tools
Track Pandion Therapeutics, Inc. Insider Activity
Get notified when executives and directors at PAND file new Form 4 transactions